摘要
目的:为了分析经 TACE 联合RFA治疗后肝癌血清铁蛋白的水平与预后的关系。方法选取中晚期肝癌患者40例,非随机分为两组,A组采用 TACE+RAF治疗,B组采用静脉化疗或最佳姑息治疗,其中男性A组16,B组4例,女性A组12例,B组8例,中位年龄A组63岁,B组61岁。分别在治疗前,治疗后1月、3月测定血清铁蛋白,两组比较。结果 A/B组治疗后血清铁蛋白水平明显下降,但A组治疗后1月、3月的下降更明显。结论血清铁蛋白的水平高低变化与肝癌的进展或好转有相关性,治疗后血清铁蛋白下降越多的,预后越好。
Objective:to analyze the joint TACE and RFA liver cancer after treatment with conventional serum ferritin level and prognosis,the relationship between.Methods:40 patients with terminal-stage liver cancer,not randomly divided into two groups,group A conventional TACE+RAF therapy,group B,intravenous chemotherapy or best pal iative care,including male 16 group A,B group of four people,women,A group of 12 people,B group of eight people,median age group A 63-year-old,group B at the age of 61.Respectively,before treatment,1 month,3 months after treatment to determine serum ferritin,comparing the two groups.Results:A/B group of serum ferritin levels significantly decreased after treatment,but 1 month,3 months after treatment group A drop is more obvious.Conclusion:the serum ferritin level changes have correlation with the progress of the liver cancer or improved,after treatment serum ferritin declined more,the bet er the prognosis.
作者
袁克华
郑建平
张培先
邓磊
龙轶
YUAN Ke-hua;ZHENG Jian-ping;ZHANG Pei-xian;DENG Lei;LONG Yi(Kunming City Yan'an Hospital,Department of Oncology,Kunming Yunnan 650051,China)